Sjogren's syndrome

被引：7

作者：

Amarasena, Roshan ^{[1
]}

Bowman, Simon ^{[1
]}

机构：

[1] Univ Hosp, NHS Fdn Trust, Birmingham B29 6JD, W Midlands, England

来源：

CLINICAL MEDICINE | 2007年 / 7卷 / 01期

关键词：

classification; diagnosis; Sjogren's syndrome; therapy;

D O I：

10.7861/clinmedicine.7-1-53

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：53 / 56

页数：4

共 13 条

[1]

[Anonymous], 2005, ARTHRITIS ALLIED CON

[2]

Barendregt PJ, 2001, ANN RHEUM DIS, V60, P876

[3] Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool [J].

Bowman, SJ ;

Booth, DA ;

Platts, RG .

RHEUMATOLOGY, 2004, 43 (06) :758-764

[4] Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells [J].

Dawson, LJ ;

Stanbury, J ;

Venn, N ;

Hasdimir, B ;

Rogers, SN ;

Smith, PM .

ARTHRITIS AND RHEUMATISM, 2006, 54 (04) :1165-1173

[5] Neurologic manifestations in primary Sjogren syndrome - A study of 82 patients [J].

Delalande, S ;

de Seze, J ;

Fauchais, AL ;

Hachulla, E ;

Stojkovic, T ;

Ferriby, D ;

Dubucquoi, S ;

Pruvo, JP ;

Vermersch, P ;

Hatron, PY .

MEDICINE, 2004, 83 (05) :280-291

[6] Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases [J].

Gottenberg, JE ;

Guillevin, L ;

Lambotte, O ;

Combe, B ;

Allanore, Y ;

Cantagrel, A ;

Larroche, C ;

Soubrier, M ;

Bouillet, L ;

Dougados, M ;

Fain, O ;

Farge, D ;

Kyndt, X ;

Lortholary, O ;

Masson, C ;

Moura, B ;

Remy, P ;

Thomas, T ;

Wendling, D ;

Anaya, JM ;

Sibilia, J ;

Mariette, X .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (06) :913-920

[7] Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome [J].

Ioannidis, JPA ;

Vassiliou, VA ;

Moutsopoulos, HM .

ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :741-747

[8] Inefficacy of infliximab in primary Sjogren's syndrome -: Results of the randomized, controlled trial of Remicade in primary Sjogren's syndrome (TRIPSS) [J].

Mariette, X ;

Ravaud, P ;

Steinfeld, S ;

Baron, G ;

Goetz, J ;

Hachulla, E ;

Combe, B ;

Puéchal, X ;

Pennec, Y ;

Sauvezie, B ;

Perdriger, A ;

Hayem, G ;

Janin, A ;

Sibilia, J .

ARTHRITIS AND RHEUMATISM, 2004, 50 (04) :1270-1276

[9] Sjogren syndrome associated with hepatitis C virus - A multicenter analysis of 137 cases [J].

Ramos-Casals, M ;

Loustaud-Ratti, V ;

De Vita, S ;

Zeher, M ;

Bosch, JA ;

Toussirot, E ;

Medina, F ;

Rosas, J ;

Anaya, JM ;

Font, J .

MEDICINE, 2005, 84 (02) :81-89

[10] Etanercept in Sjogren's syndrome - A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial [J].

Sankar, V ;

Brennan, MT ;

Kok, MR ;

Leakan, RA ;

Smith, JA ;

Manny, J ;

Baum, BJ ;

Pillemer, SR .

ARTHRITIS AND RHEUMATISM, 2004, 50 (07) :2240-2245

← 1 2 →